Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Bromelain topical - MediWound

Next Previous
Drug Profile

Bromelain topical - MediWound

Alternative Names: anacaulase-bcdb; Debrase; Debrase Gel Dressing; KMW-1; NexoBrid; NexoBridN

Latest Information Update: 01 Oct 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator MediWound
  • Developer Kaken Pharmaceutical; MediWound; Teva Pharmaceutical Industries; Tuteur
  • Class Anti-inflammatories; Cysteine endopeptidases; Skin disorder therapies
  • Mechanism of Action Peptide hydrolase replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Burns
  • New Molecular Entity No

Highest Development Phases

  • Marketed Burns
  • No development reported Wounds

Most Recent Events

  • 25 Sep 2025 Registered for Burns (In children, In adults, In infants, In neonates, In adolescents) in Australia (Topical)
  • 25 Sep 2025 MediWound plans to commercially launch Bromelain topical in Australia in Q4 2025
  • 15 Aug 2024 Launched for Burns (In neonates, In infants, In adolescents, In children) in USA (Topical)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top